Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
Lipika Goyal(Stanford Medicine), John Bridgewater(University College London Hospitals NHS Foundation Trust), Karim A. Benhadji(Dana-Farber Cancer Institute), Volker Wacheck(Taiho Oncology (United States)), Robert S. Epstein(Dana-Farber Cancer Institute), Markus Moehler(Johannes Gutenberg University Mainz), Josep Tabernero(Deaconess Hospital), Robin Kate Kelley(UCSF Helen Diller Family Comprehensive Cancer Center), Thomas B. Karasic(Hospital of the University of Pennsylvania), Philippe A. Cassier(Centre Léon Bérard), Tehseen Salimi(Dana-Farber Cancer Institute), Thomas A. Abrams(Dana-Farber Cancer Institute), Heinz‐Josef Klümpen(University Medical Center Groningen), Yoshito Komatsu(Hokkaido University Hospital), Junji Furuse(Kanagawa Prefectural Hospital Organization), Do‐Youn Oh(Seoul National University Hospital), Yao Fu(Illumina (United States)), Daniel H. Ahn(Mayo Clinic Hospital), Funda Meric‐Bernstam(The University of Texas MD Anderson Cancer Center), Juan W. Valle(Cancer Research UK Manchester Institute), Edith P. Mitchell(Thomas Jefferson University Hospital), Antoine Hollebecque(Institut Gustave Roussy), Mei Liu(Dana-Farber Cancer Institute), Abdel‐Baset Halim(Institut Gustave Roussy), Kunihiro Masuda(Tohoku University), Li‐Tzong Chen(Kaohsiung Medical University), Yaohua He(Dana-Farber Cancer Institute), Amit Mahipal(Dana-Farber Cancer Institute), Heung-Moon Chang(Ulsan College), Chigusa Morizane(Tokyo National Hospital)
Cited by 530
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k